Cargando…
Medications for analgesia and sedation in the intensive care unit: an overview
Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have p...
Autores principales: | , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391270/ https://www.ncbi.nlm.nih.gov/pubmed/18495055 http://dx.doi.org/10.1186/cc6150 |
_version_ | 1782155359215943680 |
---|---|
author | Gommers, Diederik Bakker, Jan |
author_facet | Gommers, Diederik Bakker, Jan |
author_sort | Gommers, Diederik |
collection | PubMed |
description | Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have proven to reduce the length of intensive care unit stay. To introduce these protocols, new agents or new regimens with the well established agents may be required. In this article we briefly discuss these new regimens and new agents, focusing on the short-acting substances. |
format | Text |
id | pubmed-2391270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-23912702008-05-23 Medications for analgesia and sedation in the intensive care unit: an overview Gommers, Diederik Bakker, Jan Crit Care Review Critically ill patients are often treated with continuous intravenous infusions of sedative drugs. However, this is associated with high risk for over-sedation, which can result in prolonged stay in the intensive care unit. Recently introduced protocols (daily interruption and analgosedation) have proven to reduce the length of intensive care unit stay. To introduce these protocols, new agents or new regimens with the well established agents may be required. In this article we briefly discuss these new regimens and new agents, focusing on the short-acting substances. BioMed Central 2008 2008-05-14 /pmc/articles/PMC2391270/ /pubmed/18495055 http://dx.doi.org/10.1186/cc6150 Text en Copyright © 2008 BioMed Central Ltd |
spellingShingle | Review Gommers, Diederik Bakker, Jan Medications for analgesia and sedation in the intensive care unit: an overview |
title | Medications for analgesia and sedation in the intensive care unit: an overview |
title_full | Medications for analgesia and sedation in the intensive care unit: an overview |
title_fullStr | Medications for analgesia and sedation in the intensive care unit: an overview |
title_full_unstemmed | Medications for analgesia and sedation in the intensive care unit: an overview |
title_short | Medications for analgesia and sedation in the intensive care unit: an overview |
title_sort | medications for analgesia and sedation in the intensive care unit: an overview |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2391270/ https://www.ncbi.nlm.nih.gov/pubmed/18495055 http://dx.doi.org/10.1186/cc6150 |
work_keys_str_mv | AT gommersdiederik medicationsforanalgesiaandsedationintheintensivecareunitanoverview AT bakkerjan medicationsforanalgesiaandsedationintheintensivecareunitanoverview |